The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | A | Alimentary tract and metabolism | |
| 2 | A07 | Antidiarrheals, intestinal antiinflammatory/antiinfective agents | |
| 3 | A07E | Intestinal antiinflammatory agents | |
| 4 | A07EB | Antiallergic agents, excl. corticosteroids |
| Code | Title | |
|---|---|---|
| A07EB01 | Cromoglicic acid |
| Active Ingredient | Description | |
|---|---|---|
| Cromoglicic acid |
Sodium cromoglicate (Cromoglicic acid) inhibits the activation of many of the cell types involved in the development and progression of asthma. Thus, sodium cromoglicate inhibits the release of inflammatory mediators including cytokines from mast cells and reduces the chemotactic activity of eosinophils and neutrophils. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| NALCROM Capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
